Myocet
Sponsors
Spanish Breast Cancer Research Group, Sopherion Therapeutics, Hoffmann-La Roche, West German Study Group, Martin Schrappe
Conditions
Acute Lymphoblastic Leukemia, PediatricBreast CancerEarly Primary Breast Cancer
Phase 1
Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
CompletedNCT00129896
Start: 2004-01-31End: 2010-02-28Updated: 2023-03-06
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer
CompletedNCT02015676
Start: 2001-07-31End: 2009-09-30Updated: 2015-03-12
Phase 3
Trial of Myocet in Metastatic Breast Cancer
NCT00294996
Start: 2006-01-31Updated: 2009-03-31
A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response
CompletedNCT02214381
Start: 2014-07-31End: 2025-01-15Target: 80Updated: 2025-02-27
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
RecruitingNCT03643276
Start: 2018-07-15End: 2028-07-14Target: 5000Updated: 2025-04-06